Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Garlic may help reduce side effects of breast cancer treatments.

Hair loss is a common side effect of hormone treatments for cancer.

Gene variation affects prostate issues and hair loss.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Hair analysis may help detect breast cancer early by identifying changes in lipid content.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Ficus carica leaf extract may help treat melanoma by promoting cancer cell death without harming normal cells.